Transforming growth factor-beta system and its regulation by members of the steroid-thyroid hormone superfamily
- PMID: 8902054
- DOI: 10.1016/s0065-230x(08)60872-6
Transforming growth factor-beta system and its regulation by members of the steroid-thyroid hormone superfamily
Abstract
TGF-beta s and their receptors are expressed ubiquitously, and they act as key regulators of many aspects of cell growth, differentiation, and function. Steroid action on target tissues is often associated with increase in TGF-beta isoforms. Regulation of TGF-beta expression and activation is crucial for normal development and growth control. The loss of responsiveness of different tumor cells to the antiproliferative effects of TGF-beta is a common feature in carcinogenesis. Multiple changes are required for the cells to gain complete resistance to TGF-beta growth inhibition (Fynan and Reiss, 1993; Kimchi et al., 1988; Samuel et al., 1992). Although many tumor cells are not growth inhibited by TGF-beta, they respond to TGF-beta treatment by changes in the expression of matrix components and enhanced proteolytic activity (KeskiOja et al., 1988). Agents that induce TGF-beta production in target tissues can have a chemopreventive or chemotherapeutic value for the management of epithelial malignancies. Conversely, data supporting a positive role for TGF-beta in established tumor progression are beginning to emerge (Arteaga et al., 1993a,b; Barrett-Lee et al., 1990; Arrick et al., 1992 ; E. A. Thompson et al., 1991). In later stages of tumor development, cell proliferation is often not inhibited by TGF-beta, and tumor cells secrete large amounts of this growth factor (Fynan and Reiss, 1993). In vivo TGF-beta secreted by tumor or stromal cells can influence host responses such as a natural killer cell function and thus indirctly support tumor cell viability (Arteaga et al., 1993b). TGF-beta may also affect tumor growth indirectly by stromal effects and promotion of angiogenesis. TGF-beta may also be involved in the progression of breast tumors from the steroid-sensitive to steroid-insensitive state (King et al., 1989). Understanding of the net effect of TGF-beta in different stages of tumor development is critical for the evaluation of its therapeutic value in cancer treatment.
Similar articles
-
Regulation of transforming growth factor-beta subtypes by members of the steroid hormone superfamily.J Cell Sci Suppl. 1990;13:139-48. doi: 10.1242/jcs.1990.supplement_13.13. J Cell Sci Suppl. 1990. PMID: 2084113 Review.
-
Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.Cancer Res. 1994 Nov 15;54(22):5867-74. Cancer Res. 1994. PMID: 7954416
-
Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.Cancer Res. 2002 May 15;62(10):2778-90. Cancer Res. 2002. PMID: 12019154
-
Regulation of growth and gene expression in human papillomavirus-transformed keratinocytes by transforming growth factor-beta: implications for the control of papillomavirus infection.Mol Carcinog. 1992;6(2):100-11. doi: 10.1002/mc.2940060205. Mol Carcinog. 1992. PMID: 1326988
-
Transforming growth factor-beta in cancer and metastasis.Cancer Metastasis Rev. 2006 Sep;25(3):435-57. doi: 10.1007/s10555-006-9006-2. Cancer Metastasis Rev. 2006. PMID: 16951986 Review.
Cited by
-
Immunosuppressive therapy modulates T lymphocyte gene expression in patients with systemic lupus erythematosus.Immunology. 2004 Sep;113(1):99-105. doi: 10.1111/j.1365-2567.2004.01929.x. Immunology. 2004. PMID: 15312140 Free PMC article.
-
Transforming growth factor beta2 induced pleurodesis is not inhibited by corticosteroids.Thorax. 2001 Aug;56(8):643-8. doi: 10.1136/thorax.56.8.643. Thorax. 2001. PMID: 11462068 Free PMC article.
-
Contributions of Thyroid Hormone to Cancer Metastasis.Biomedicines. 2018 Aug 22;6(3):89. doi: 10.3390/biomedicines6030089. Biomedicines. 2018. PMID: 30135398 Free PMC article. Review.
-
Role of genetic polymorphisms in tumour angiogenesis.Br J Cancer. 2002 Nov 4;87(10):1057-65. doi: 10.1038/sj.bjc.6600625. Br J Cancer. 2002. PMID: 12402142 Free PMC article. Review.
-
Transforming growth factor beta may act as an autocrine-survival-promoting factor for transformed trophoblasts.In Vitro Cell Dev Biol Anim. 2001 Apr;37(4):245-50. doi: 10.1007/BF02577537. In Vitro Cell Dev Biol Anim. 2001. PMID: 11409691
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources